SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
For Quarterly Period Ended December 31, 2022
or
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission File Number 0-28585
AuraSource, Inc.
(Exact name of registrant as specified in its charter)
Nevada
(State or Other Jurisdiction of Incorporation or Organization)
2103 E. Cedar St., Suite 6, Tempe, AZ 85281
(Address of principal executive offices, zip code)
Registrant's telephone number (including area code): (480) 553-1778
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
YES [ ] NO [x]
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (section 232.405 of this chapter) during the preceding twelve months (or shorter period that the registrant was required to submit and post such files).
YES [x] NO [ ]
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act.
Large Accelerated Filer [ ] Accelerated Filer [ ] Non-accelerated Filer [x] Smaller reporting company [x] Emerging growth company [x]
Indicate by check mark whether the registrant is a shell company (as defined in Rule12b-2 of the Act). Yes [x] No [ ]
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes [ ] No [x]
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.
Class | Outstanding at February 13, 2023 | |
Common Stock, $.001 par value | 68,898,151 |
AURASOURCE, INC.
INDEX
PART I | FINANCIAL INFORMATION | Page |
ITEM 1. | CONSOLIDATED FINANCIAL STATEMENTS: | |
Condensed Consolidated Balance Sheets — December 31, 2022 and March 31, 2022 | 3 | |
Condensed Consolidated Statements of Operations and Comprehensive Income (Unaudited) – Three and Nine Months Ended December 31, 2022 and 2021 | 4 | |
Consolidated Statements of Stockholders’ Deficit (Unaudited) – Three and Nine Months Ended December 31, 2022 and 2021 | 5 | |
Condensed Consolidated Statements of Cash Flows (Unaudited) – Nine Months Ended December 31, 2022 and 2021 | 6 | |
Notes to Unaudited Condensed Consolidated Financial Statements | 7 | |
ITEM 2. | MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS | 15 |
ITEM 3. | QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK | 19 |
ITEM 4. | CONTROLS AND PROCEDURES | 19 |
PART II | OTHER INFORMATION | 20 |
ITEM 4. | SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS | 20 |
ITEM 6. | EXHIBITS | 21 |
Signatures | 22 |
-2- |
PART I - FINANCIAL INFORMATION
ITEM 1 — CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
AuraSource, Inc.
Condensed Consolidated Balance Sheets
(Unaudited)
December 31, 2022 | March 31, 2022 | |||||||
ASSETS | ||||||||
CURRENT ASSETS | ||||||||
Cash | $ | 21,278 | $ | 3,437 | ||||
TOTAL CURRENT ASSETS | 21,278 | 3,437 | ||||||
Deposit | 2,262 | 2,262 | ||||||
Operating lease right-of-use assets, net | 67,958 | 5,145 | ||||||
Intangibles | 254 | — | ||||||
TOTAL ASSETS | $ | 91,752 | $ | 10,844 | ||||
LIABILITIES AND STOCKHOLDERS' DEFICIT | ||||||||
CURRENT LIABILITIES | ||||||||
Accounts payable | $ | 98,092 | $ | 136,107 | ||||
Accounts payable – related parties | 3,107,267 | 2,787,773 | ||||||
Operating lease obligations, current | 25,639 | 4,606 | ||||||
Note payable and accrued interest | 120,147 | 119,594 | ||||||
Note payable and accrued interest – related parties | 2,960,662 | 2,750,548 | ||||||
TOTAL CURRENT LIABILITIES | 6,311,807 | 5,798,628 | ||||||
Operating lease obligations, long term | 42,551 | — | ||||||
TOTAL LIABILITIES | 6,354,358 | 5,798,628 | ||||||
Commitments and contingencies | — | — | ||||||
STOCKHOLDERS' DEFICIT | ||||||||
Preferred stock, 10,000 shares authorized, no shares issued and outstanding, no rights or privileges designated | — | — | ||||||
Common stock, $0.001 par value, 150,000,000 shares authorized, 68,898,151 and 68,208,151 shares issued and outstanding at December 31, 2022 and March 31, 2022, respectively | 68,898 | 68,208 | ||||||
Additional paid in capital | 14,897,779 | 14,724,399 | ||||||
Accumulated other comprehensive income | 54,950 | 13,223 | ||||||
Accumulated deficit | (21,284,233 | ) | (20,593,614 | ) | ||||
Total stockholders' deficit | (6,262,606 | ) | (5,787,784 | ) | ||||
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT | $ | 91,752 | $ | 10,844 | ||||
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
-3- |
AuraSource, Inc.
Condensed Consolidated Statements of Operations
(Unaudited)
Three Months Ended December 31, | Nine Months Ended December 31, | |||||||||||||||
2022 | 2021 | 2022 | 2021 | |||||||||||||
Revenue | $ | 120,500 | $ | — | $ | 120,500 | $ | — | ||||||||
Cost of revenue | 92,388 | — | 92,388 | — | ||||||||||||
Gross profit | 28,112 | — | 28,112 | — | ||||||||||||
Operating expenses: | ||||||||||||||||
General & administrative expenses | 136,912 | 212,687 | 423,586 | 624,023 | ||||||||||||
Total operating expenses | 136,912 | 212,687 | 423,586 | 624,023 | ||||||||||||
Loss from operations | (108,800 | ) | (212,687 | ) | (395,476 | ) | (624,023 | ) | ||||||||
Interest income (expense) and other, net | (101,627 | ) | (91,416 | ) | (295,143 | ) | (264,046 | ) | ||||||||
Net loss | (210,427 | ) | (304,103 | ) | (690,619 | ) | (888,069 | ) | ||||||||
Other Comprehensive Income | ||||||||||||||||
Foreign currency translation gain (loss) | (13,493 | ) | 7,273 | 41,727 | 16,869 | |||||||||||
Total Comprehensive Loss | $ | (223,930 | ) | $ | (296,830 | ) | $ | (648,892 | ) | $ | (871,200 | ) | ||||
Basic & diluted loss per share | $ | (0.00 | ) | $ | (0.00 | ) | $ | (0.01 | ) | $ | (0.01 | ) | ||||
Weighted average shares outstanding – basic & diluted | 68,780,759 | 68,208,151 | 68,544,005 | 68,208,151 |
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
-4- |
AuraSource, Inc.
Unaudited Consolidated Statements of Stockholders’ Deficit
Three and Nine Months ended December 31, 2022 and 2021
Three Month Comparison
Preferred Stock | Common Stock | ||||||||||||||||||||||||||||||
Shares | Amount | Shares | Amount | APIC | Accumulated Deficit | Other Comprehensive Income | Total | ||||||||||||||||||||||||
Balance at September 30, 2022 | — | $ | — | 68,598,151 | $ | 68,598 | $ | 14,837,490 | $ | (21,073,805) | $ | 68,444 | $ | (6,099,274) | |||||||||||||||||
Issuance of common stock | 300,000 | 300 | 14,700 | 15,000 | |||||||||||||||||||||||||||
Issuance of options | — | — | — | — | 18,400 | — | — | 18,400 | |||||||||||||||||||||||
Imputed interest | 27,190 | 27,190 | |||||||||||||||||||||||||||||
Net loss | — | — | — | — | — | (210,427) | — | (210,427) | |||||||||||||||||||||||
Foreign currency translation adjustment | — | — | — | — | — | — | (13,494) | (13,494) | |||||||||||||||||||||||
Balance at December 31, 2022 | — | $ | — | 68,898,151 | $ | 68,898 | $ | 14,897,779 | $ | (21,284,233) | $ | 54,950 | $ | (6,262,606) |
Preferred Stock | Common Stock | ||||||||||||||||||||||||||||||
Shares | Amount | Shares | Amount | APIC | Accumulated Deficit | Other Comprehensive Income | Total | ||||||||||||||||||||||||
Balance at September 30, 2021 | — | $ | — | 68,208,151 | $ | 68,208 | $ | 14,561,971 | $ | (20,047,883) | $ | 21,628 | $ | (5,396,075) | |||||||||||||||||
Issuance of options | — | — | — | — | 90,000 | — | — | 90,000 | |||||||||||||||||||||||
Imputed interest | 23,435 | 23,435 | |||||||||||||||||||||||||||||
Net loss | — | — | — | — | — | (304,103) | — | (304,103) | |||||||||||||||||||||||
Foreign currency translation adjustment | — | — | — | — | — | — | (7,274) | (7,274) | |||||||||||||||||||||||
Balance at December 31, 2021 | — | $ | — | 68,208,151 | $ | 68,208 | $ | 14,675,406 | $ | (20,351,986) | $ | 14,354 | $ | (5,594,017) |
Nine Month Comparison
Nine Month Comparison
Preferred Stock | Common Stock | ||||||||||||||||||||||||||||||
Shares | Amount | Shares | Amount | APIC | Accumulated Deficit | Other Comprehensive Income | Total | ||||||||||||||||||||||||
Balance at March 31, 2022 | — | $ | — | 68,208,151 | $ | 68,208 | $ | 14,724,399 | $ | (20,593,614) | $ | 13,223 | $ | (5,787,784) | |||||||||||||||||
Issuance of common stock | 690,000 | 690 | 33,810 | 34,500 | |||||||||||||||||||||||||||
Issuance of options | — | — | — | — | 60,800 | — | — | 60,800 | |||||||||||||||||||||||
Imputed interest | 78,770 | 78,770 | |||||||||||||||||||||||||||||
Net loss | — | — | — | — | — | (690,619) | — | (690,619) | |||||||||||||||||||||||
Foreign currency translation adjustment | — | — | — | — | — | — | 41,727 | 41,727 | |||||||||||||||||||||||
Balance at December 31, 2022 | — | $ | — | 68,898,151 | $ | 68,898 | $ | 14,897,779 | $ | (21,284,233) | $ | 54,950 | $ | (6,262,606) |
| Preferred Stock | Common Stock | |||||||||||||||||||||||||||||
Shares | Amount | Shares | Amount | APIC | Accumulated Deficit | Other Comprehensive Income | Total | ||||||||||||||||||||||||
Balance at March 31, 2021 | — | $ | — | 68,208,151 | $ | 68,208 | $ | 14,357,975 | $ | (19,463,917) | $ | 31,223 | $ | (5,006,511) | |||||||||||||||||
Issuance of options | — | — | — | 250,000 | — | — | 250,000 | ||||||||||||||||||||||||
Imputed interest | 67,431 | 67,431 | |||||||||||||||||||||||||||||
Net loss | — | — | — | — | — | (888,069) | — | (888,069) | |||||||||||||||||||||||
Foreign currency translation adjustment | — | — | — | — | — | — | (16,869) | (16,869) | |||||||||||||||||||||||
Balance at December 31, 2021 | — | $ | — | 68,208,151 | $ | 68,208 | $ | 14,675,406 | $ | (20,351,986) | $ | 14,354 | $ | (5,594,018) |
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
-5- |
AuraSource, Inc.
Condensed Consolidated Statements of Cash Flows
(Unaudited)
Nine Months Ended December 31, | ||||||||
2022 | 2021 | |||||||
Cash flows from operating activities | ||||||||
Net loss | $ | (690,619 | ) | $ | (888,069 | ) | ||
Adjustments to reconcile net loss to net cash used in operating activities | ||||||||
Imputed interest - related parties | 78,771 | 67,431 | ||||||
Options issued for services | 60,800 | 250,000 | ||||||
Changes in operating assets and liabilities | ||||||||
Accounts payable and accrued expenses | (37,245 | ) | 16,048 | |||||
Accounts payable – related parties | 529,608 | 521,285 | ||||||
Interest payable | 553 | 3,825 | ||||||
Net cash used in operating activities | (58,132 | ) | (29,480 | ) | ||||
Cash flows from investing activities | ||||||||
Cash paid for patents | (254 | ) | — | |||||
Net cash provided by investing activities | (254 | ) | — | |||||
Cash flows from financing activities | ||||||||
Proceeds from issuance of common stock, net | 34,500 | — | ||||||
Net cash provided by financing activities | 34,500 | — | ||||||
Effect of exchange rate fluctuation on cash | 41,727 | (16,869 | ) | |||||
Net change in cash and equivalents | 17,841 | (46,349 | ) | |||||
Cash - beginning balance | 3,437 | 65,887 | ||||||
Cash - ending balance | $ | 21,278 | $ | 19,538 |
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION | ||||||||
Cash paid during the period for | ||||||||
Interest | $ | — | $ | — | ||||
Income taxes | $ | — | $ | — | ||||
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
-6- |
AuraSource, Inc.
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Current Operations and Background — AuraSource, Inc. (“AuraSource” or “Company”) focuses on two areas AuraMetal and AuraMoto.
AuraMetalTM is focused on the development and production of environmentally friendly and cost-effective beneficiation process for complex ore, tailings and slimes materials as industrial application solutions. AuraSource’s core technology includes physical separation, hydrometallurgical and pyrometallurgy processes. We have developed seven patented technologies: 1) ultrafine grinding and 2) ultrafine separation. To date, we have not had any sustainable projects. As such, there can be no assurances that our efforts towards this line of business will succeed.
AuraMotoTM is focused on sourcing various vendors and customers in the automotive industry. We entered into the industry due to our various international sourcing contacts. We have been requested from various parties to source vendors and customers in the automotive industry. This business line is still in development. As this is a new enterprise for the Company, there can be no assurances that our efforts towards this line of business will succeed.
There can be no assurance we will be able to carry out our development plans for AuraMetals or AuraMoto. Our ability to pursue this strategy is subject to the availability of additional capital and further development of our technology. We also need to finance the cost of effectively protecting our intellectual property rights in the United States (“US”) and abroad where we intend to market our technology and products.
Going Concern — The accompanying unaudited consolidated financial statements were prepared assuming the Company will continue as a going concern. The Company has suffered recurring losses from operations since its inception and has an accumulated deficit of $21,284,233 at December 31, 2022. The consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts and classifications of liabilities that might be necessary should the Company be unable to continue its existence. The recovery of the Company’s assets is dependent upon continued operations of the Company. In addition, the Company's recovery is dependent upon future events, the outcome of which is undetermined. The Company intends to continue to attempt to raise additional capital, but there can be no certainty such efforts will be successful.
Management’s Plan to Continue as a Going Concern
In order to continue as a going concern, the Company will need, among other things, additional capital resources. Management’s plans to obtain such resources for the Company include (1) obtaining capital from the sale of its equity securities, (2) sales of its products, and (3) short-term or long-term borrowings from banks, stockholders or other party(ies) when needed. However, management cannot provide any assurance that the Company will be successful in accomplishing any of its plans. The Company plans to look for opportunities to merge with other companies in the graphite industry.
The ability of the Company to continue as a going concern is dependent upon its ability to successfully accomplish the plans described in the preceding paragraph and eventually to secure other sources of financing and attain profitable operations.
-7- |
Revenue Recognition - The Company recognizes revenue in accordance with ASC 606, Revenue Recognition. ASC 606 requires that five basic criteria must be met before revenue can be recognized:
- Identify the contract(s) with a customer
- Identify the performance obligations in the contract
- Determine the transaction price
- Allocate the transaction price to the performance obligations in the contract
- Recognize revenue when or as you satisfy a performance obligation
When we are paid in advance for products or services, we classify these amounts as deferred revenue. Upon the receipt of these products at the factory, we recognize revenue which is the time we transfer control to the customer. For services, we recognize revenue when the services are complete.
Basis of Presentation and Principles of Consolidation — The accompanying condensed consolidated financial statements were prepared in conformity with accounting principles generally accepted in the United States of America (“US GAAP”) and include the accounts of AuraSource and its subsidiary, Qinzhou. All significant intercompany transactions and balances were eliminated in consolidation.
The unaudited consolidated financial statements were prepared by us pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). The information furnished herein reflects all adjustments (consisting of normal recurring accruals and adjustments) which are, in the opinion of management, necessary to fairly present the operating results for the respective periods. Certain information and footnote disclosures normally present in annual consolidated financial statements prepared in accordance with US GAAP was omitted pursuant to such rules and regulations. These consolidated financial statements should be read in conjunction with the audited consolidated financial statements and footnotes for the year ended March 31, 2022 included in our Annual Report on Form 10-K. The results of the three and nine months ended December 31, 2022 are not necessarily indicative of the results to be expected for the full year ending March 31, 2023.
Use of Estimates — The preparation of consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Cash and Equivalents — We consider investments with original maturities of 90 days or less to be cash equivalents.
Property and Equipment - Property and Equipment are stated at historical cost less accumulated depreciation and amortization. Cost represents the purchase price of the asset and other costs incurred to bring the asset into its existing use. Depreciation is provided on a straight-line basis over the assets' estimated useful lives. The useful lives of the assets are as follows: machinery and equipment 3 years, office equipment 3 years, vehicles 5 years. Additions and improvements are capitalized while routine repairs and maintenance are charged to expense as incurred. Upon sale or disposition, the historically recorded asset cost and accumulated depreciation are removed from the accounts and the net amount less proceeds from disposal is charged or credited to other income / expense.
-8- |
Leases- In February 2016, the FASB established Topic 842, Leases, by issuing ASU No. 2016-02, which requires lessees to recognize the rights and obligations created by leases on the balance sheet and disclose key information about leasing arrangements. Topic 842 was subsequently amended by ASU No. 2018-11, Targeted Improvements, ASU No. 2018-10, Codification Improvements to Topic 842, and ASU No. 2018-01, Land Easement Practical Expedient for Transition to Topic 842. The new standard establishes a right-of-use model (ROU) that requires a lessee to recognize a ROU asset and lease liability on the balance sheet for all leases with a term longer than 12 months. Leases will be classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the statement of operations.
The new standard became effective April 1, 2019. A modified retrospective transition approach is required, applying the new standard to all leases existing at the date of initial application. An entity may choose to use either (1) its effective date or (2) the beginning of the earliest comparative period presented in the financial statements as its date of initial application. If an entity chooses the second option, the transition requirements for existing leases also apply to leases entered into between the date of initial application and the effective date. The entity must also recast its comparative period financial statements and provide the disclosures required by the new standard for the comparative periods. The Company adopted the new standard on April 1, 2019 using the modified retrospective transition approach as of the effective date of the initial application. Consequently, financial information will not be updated and the disclosures required under the new standard will not be provided for dates and periods before January 1, 2019. The new standard provides a number of optional practical expedients in transition. The Company elected the “package of practical expedients”, which permits entities not to reassess under the new lease standard prior conclusions about lease identification, lease classification and initial direct costs. The Company does not expect to elect the use-of-hindsight or the practical expedient pertaining to land easements.
The most significant effects of the adoption of the new standard relate to the recognition of new ROU assets and lease labilities on our balance sheet for office operating leases and providing significant new disclosures about our leasing activities.
The new standard also provides practical expedients for an entity’s ongoing accounting. The Company has also elected the short-term leases recognition exemption for all leases that qualify. This means that the Company will not recognize ROU assets or lease liabilities, and this includes not recognizing ROU assets and lease liabilities, for existing short-term leases of those assets in transition. The Company also currently expects to elect the practical expedient to not separate lease and non-lease components for its leases. The new standard did not have a material impact.
Impairment of Long-Lived Assets and Long-Lived Assets to Be Disposed Of- In accordance with ASC 350-30, we evaluate long-lived assets for impairment whenever events or changes in circumstances indicate that their net book value may not be recoverable. When such factors and circumstances exist, we compare the projected undiscounted future cash flows associated with the related asset or group of assets over their estimated useful lives against their respective carrying amount. Impairment, if any, is based on the excess of the carrying amount over the fair value, based on market value when available, or discounted expected cash flows, of those assets and is recorded in the period in which the determination is made. We currently believe there is no impairment of our long-lived assets. There can be no assurance, however, that market conditions will not change or demand for our products under development will continue. Either of these could result in future impairment of long-lived assets.
-9- |
Income Taxes — The Company accounts for income taxes in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 740, “Income Taxes.” Deferred tax assets and liabilities are recognized to reflect the estimated future tax effects, calculated at currently effective tax rates, of future deductible or taxable amounts attributable to events that have been recognized on a cumulative basis in the financial statements. A valuation allowance for a deferred tax asset is recorded when it is more likely than not that some portion of the deferred tax asset will not be realized.
Stock-Based Compensation — The Company recognizes the options and restricted stock awards to employees at grant date fair-value of the instruments in the consolidated financial statements over the period the employee is required to perform the services.
Foreign Currency Translation. - Our consolidated financial statements are expressed in U.S. dollars, but the functional currency of our operating subsidiary is RMB. Results of operations and cash flows are translated at average exchange rates during the period, assets and liabilities are translated at the unified exchange rate at the end of the period and equity is translated at historical exchange rates. Translation adjustments resulting from the process of translating the financial statements denominated in RMB into U.S. dollars are included in determining comprehensive income.
Net Loss Per Share — The Company computes basic and diluted net loss per share by dividing the net loss available to common stockholders for the period by the weighted average number of shares of common stock outstanding during the period. Common equivalent shares arising from stock options and warrants were excluded from the computation of basic and diluted earnings per share, for the three and nine months ended December 31, 2022 and 2021 because their effect is anti-dilutive.
The table below presents the computation of basic and diluted earnings per share for the three and nine months ended December 31, 2022 and 2021:
For the | For the | For the | For the | |||||||||||||
three months ended | three months ended | nine months ended | nine months ended | |||||||||||||
December 31, 2022 | December 31, 2021 | December 31, 2022 | December 31, 2021 | |||||||||||||
Numerator: | ||||||||||||||||
Net loss | $ | (210,427 | ) | $ | (304,103 | ) | $ | (690,619 | ) | $ | (888,069 | ) | ||||
Denominator: | ||||||||||||||||
Weighted average common shares outstanding—basic | 68,780,759 | 68,208,151 | 68,544,005 | 68,208,151 | ||||||||||||
Dilutive common stock equivalents | 7,480,000 | 6,880,000 | 7,480,000 | 6,880,000 | ||||||||||||
Weighted average common shares outstanding—diluted | 76,260,759 | 75,088,151 | 76,024,005 | 75,088,151 | ||||||||||||
Net loss per share: | ||||||||||||||||
Basic | $ | (0.00 | ) | $ | (0.00 | ) | $ | (0.01 | ) | $ | (0.01 | ) | ||||
Diluted | $ | (0.00 | ) | $ | (0.00 | ) | $ | (0.01 | ) | $ | (0.01 | ) |
Concentration of Credit Risk — Financial instruments that potentially subject the Company to a concentration of credit risk consist of cash. The Company maintains its cash with high credit quality financial institutions; at times, such balances with any one financial institution may exceed Federal Deposit Insurance Corporation (“FDIC”) insured limits.
-10- |
Financial Instruments and Fair Value of Financial Instruments — Our financial instruments consist of cash, accounts payable and notes payable. The carrying values of cash, accounts payable and notes payable are representative of the fair values due to their short-term maturities. We measure the fair value (“FV”) of financial assets and liabilities on a recurring basis. FV is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. FV measurements are to be considered from the perspective of a market participant that holds the asset or owes the liability. We also establish a FV hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring FV.
The standard describes three levels of inputs that may be used to measure FV:
Level 1: | Quoted prices in active markets for identical or similar assets and liabilities. | |
Level 2: | Quoted prices for identical or similar assets and liabilities in markets that are not active or observable inputs other than quoted prices in active markets for identical or similar assets and liabilities. | |
Level 3: | Unobservable inputs that are supported by little or no market activity and that are significant to the FV of the assets or liabilities. |
The Company evaluates embedded conversion features within convertible debt under ASC Topic 815, “Derivatives and Hedging,” to determine whether the embedded conversion feature should be bifurcated from the host instrument and accounted for as a derivative at FV with changes in FV recorded in earnings.
Recently Issued Accounting Standards
In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-06, Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective January 1, 2022 and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company adopted ASU 2020-06 effective January 1, 2021. The adoption of ASU 2020-06 did not have an impact on the Company’s financial statements.
NOTE 2 - CONCENTRATION OF CREDIT RISK
As of December 31, 2022 and March 31, 2022, our deposits did not exceed amounts insured by the FDIC (up to $250,000, per financial institution as of December 31, 2022). We have not experienced any losses in such accounts, and we believe we are not exposed to any credit risk on cash.
Currently, we maintain a bank account in China. This account is not insured, and we believe is exposed to credit risk on cash.
Currently, all of our revenue is from one customer.
-11- |
NOTE 3 – ACCOUNTS PAYABLE – RELATED PARTIES
As of December 31, 2022 and March 31, 2022, $3,107,267 and $2,787,773, respectively, is owed to the officers and directors. Since December 2011, the officers and directors of the Company agreed to accrue compensation for their services until such time the Company had sufficient funds to pay this liability.
NOTE 4 – NOTE PAYABLE – RELATED PARTY
On April 26, 2016, we entered into a note payable with Philip Liu, our CEO, whereby he converted amounts owed of $1,565,169. On February 15, 2018, Mr. Liu converted $303,266 of the note into 4,332,374 shares of common stock which was considered the fair market value. $2,314,922 is owed under the note as of December 31, 2022. The note has an interest rate of 10% which is compounded quarterly is in default.
On April 26, 2016, we entered into a note payable with Eric Stoppenhagen, our CFO, whereby he converted amounts owed of $411,214. On February 15, 2018, Mr. Stoppenhagen converted $91,950 of the note into 1,313,556 shares of common stock which was considered the fair market value. $645,740 is owed under the note as of December 31, 2022. The note has an interest rate of 10% which is compounded quarterly is in default.
NOTE 5 – NOTE PAYABLE
In December 2014, we entered into a note payable for $63,357 which bears an interest rate of 6% per year as a settlement for previously due amounts recorded in accounts payable. The Company paid $7,500 to reduce the amount of the note. The amount of principal and interest as of December 31, 2022 is $92,123. The principal and interest are due on September 15, 2016. The note payable is currently in default.
On May 3, 2020, we entered into a loan borrowed $29,332 from Bank of America (“Lender”), pursuant to a Promissory Note issued by Company to Lender (the “PPP Note”). The loan was made pursuant to the Payroll Protection Program established as part of the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”). The PPP Note bears interest at 1.00% per annum, payable monthly beginning December 3, 2020, and is due on May 3, 2022. The PPP Note may be repaid at any time without penalty. The PPP Note contains customary events of default relating to, among other things, payment defaults, breach of representations and warranties, or provisions of the promissory note. The occurrence of an event of default may result in a claim for the immediate repayment of all amounts outstanding under the PPP Note. We repaid $10,000 in August 2020. As of December 31, 2022, the principal and interest of the PPP Note is $13,837. The Company plans to pay off this loan balance in the next year.
On June 13, 2020, we entered into a note with the US Small Business Administration for a loan amount of $12,900 and an annual interest rate of 3.75% which is due in 30 years. As of December 31, 2022, the principal and interest of the note is $14,186.
NOTE 6 – STOCK ISSUANCE
During the quarter ended June 30, 2022, the Company issued 190,000 shares of common stock for $9,500.
During the quarter ended September 30, 2022, the Company issued 200,000 shares of common stock for $10,000.
-12- |
During the quarter ended December 31, 2022, the Company issued 300,000 shares of common stock for $15,000.
As of December 31, 2022, there are 68,898,151 shares of common stock issued and outstanding.
NOTE 7 - STOCK OPTIONS
On April 1, 2021, we granted 200,000 vested options to purchase shares of our common stock at $0.052 per share to certain our CEO and CFO per their employment agreements. On July 1, 2021, we granted 200,000 vested options to purchase shares of our common stock at $0.052 per share to certain our CEO and CFO per their employment agreements. On October 1, 2021, we granted 200,000 vested options to purchase shares of our common stock at $0.052 per share to certain our CEO and CFO per their employment agreements. On January 1, 2022, we granted 200,000 vested options to purchase shares of our common stock at $0.052 per share to certain our CEO and CFO per their employment agreements. On April 1, 2022, we granted 200,000 vested options to purchase shares of our common stock at $0.052 per share to certain our CEO and CFO per their employment agreements. On July 1, 2022, we granted 200,000 vested options to purchase shares of our common stock at $0.052 per share to certain our CEO and CFO per their employment agreements. All options have a term of ten years. On October 1, 2022, we granted 200,000 vested options to purchase shares of our common stock at $0.052 per share to certain our CEO and CFO per their employment agreements. All options have a term of ten years.
We will record stock-based compensation expense over the requisite service period, which in our case approximates the vesting period of the options. During the nine months ended December 31, 2022 and 2021, the Company recorded $60,800 and $250,000, respectively, in compensation expense arising from the vesting of options, respectively. The Company assumed all stock options issued during the quarter will vest. Though these expenses result in a deferred tax benefit, we have a full valuation allowance against the deferred tax benefit.
The Company adopted the detailed method provided in FASB ASC Topic 718, “Compensation – Stock Compensation,” for calculating the beginning balance of the additional paid-in capital pool (“APIC pool”) related to the tax effects of employee stock-based compensation, and to determine the subsequent impact on the APIC pool and Consolidated Statements of Cash Flows of the income tax effects of employee stock-based compensation awards that are outstanding.
The fair value of each stock option granted is estimated on the grant date using the Black-Scholes option pricing model (“BSOPM”). The BSOPM has assumptions for risk free interest rates, dividends, stock volatility and expected life of an option grant. The risk-free interest rate is based upon market yields for United States Treasury debt securities at a 10-year constant maturity. Dividend rates are based on the Company’s dividend history. The stock volatility factor is based on the last five years of market prices prior to the grant date. The expected life of an option grant is based on management’s estimate. The fair value of each option grant, as calculated by the BSOPM, is recognized as compensation expense on a straight-line basis over the vesting period of each stock option award.
These assumptions were used to determine the FV of stock options granted:
Dividend yield | 0.0% | |||
Volatility | 350% | |||
Average expected option life | 5 years | |||
Risk-free interest rate | 2.39% - 2.88% |
-13- |
The following table summarizes activity in the Company's stock option grants for the nine months ended December 31, 2022 and year ended March 31, 2022:
Number of Shares | Weighted Average Price Per Share | Weighted Average Contractual Term (in years) | Aggregate Intrinsic Value | |||||||||||||
Balance at March 31, 2021 | 6,120,000 | $ | 0.25 | 3.50 | $ | - | ||||||||||
Granted | 800,000 | $ | 0.05 | 3.50 | $ | 33,600 | ||||||||||
Expired | (40,000) | $ | 0.75 | 0.00 | $ | |||||||||||
Balance at March 31, 2022 | 6,880,000 | $ | 0.24 | 3.50 | $ | - | ||||||||||
Granted | 600,000 | $ | 0.05 | 4.50 | $ | 16,800 | ||||||||||
Balance at December 31, 2022 | 7,480,000 | $ | 0.24 | 3.75 | $ | - |
NOTE 8 - COMMITMENTS AND CONTINGENCIES
Leases — We currently lease 2,507 square feet of office space at 2103 E. Cedar Street, Suites 6 Tempe, Arizona for $2,565 per month. The lease expires June 30, 2025 and $79,710 is due through the remainder of the lease. We believe that our facilities are adequate to meet our current and near-term needs.
December 31, 2022 | |||
Lease Cost | |||
Operating lease cost (included in general and administration in the Company’s statement of operations) | $ | 22,493 | |
Other Information | |||
Cash paid for amounts included in the measurement of lease liabilities for the nine months ended December 31, 2022 | $ | 21,928 | |
Remaining lease term – operating leases (in years) | 4.500 | ||
Average discount rate – operating leases | 10% | ||
The supplemental balance sheet information related to leases for the periods are as follows: | |||
Operating leases | |||
Right-of-use assets | $ | 67,958 | |
Total operating lease assets | $ | 67,958 | |
Short-term operating lease liabilities | $ | 25,639 | |
Long-term operating lease liabilities | $ | 42,551 | |
Total operating lease liabilities | $ | 68,190 | |
Maturities of the Company’s lease liabilities are as follows: | |||
Period ending December 31, | Operating | ||
Lease | |||
2023 | 79,710 | ||
Total lease payments | 79,710 | ||
Less: Imputed interest/present value discount | 11,520 | ||
Present value of lease liabilities | $ | 68,190 |
-14- |
ITEM 2 - MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The information contained in this Form 10-Q is intended to update the information contained in our Annual Report on Form 10-K for the year ended March 31, 2022 and presume readers have access to, and will have read, the “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and other information contained in such Form 10-K. The following discussion and analysis also should be read together with our consolidated financial statements and the notes to the consolidated financial statements included elsewhere in this Form 10-Q.
The following discussion contains certain statements that may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements appear in a number of places in this Report, including, without limitation, “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” These statements are not guarantees of future performance and involve risks, uncertainties and requirements that are difficult to predict or are beyond our control. Forward-looking statements speak only as of the date of this quarterly report. You should not put undue reliance on any forward-looking statements. We strongly encourage investors to carefully read the factors described in our Annual Report on Form 10-K for the year ended March 31, 2022 in the section entitled “Risk Factors” for a description of certain risks that could, among other things, cause actual results to differ from these forward-looking statements. We assume no responsibility to update the forward-looking statements contained in this quarterly report on Form 10-Q. The following should also be read in conjunction with the unaudited consolidated financial statements and notes thereto that appear elsewhere in this report.
Overview
AuraSource focuses on the development and production of environmentally friendly and cost-effective beneficiation process for complex ore, tailings and slimes materials as industrial application solutions. AuraSource’s core technology includes physical separation, hydrometallurgical and pyrometallurgy processes.
Recently, due to our various international sourcing contacts, we have been requested from various parties to source vendors and customers in the automotive industry. There can be no assurances that our efforts towards this line of business will succeed.
AuraSource’s physical separation includes ultrafine grinding and impurities removal, which separate metallic and non-metallic minerals. AuraSource develops and tests hydrometallurgical flow sheets for the recovery and refining of metals from concentrate leaching, precipitation, cementation, ion-exchange, solvent extraction, electro-winning, and process simulations. AuraSource also carries out high-temperature research and process development for the production of a wide variety of mineral commodities.
AuraSource formed AuraSource Qinzhou, to acquire these types of technologies, performing R&D related to the reduction of harmful emissions and energy costs. AuraSource is currently looking to license this technology to third parties through joint ventures with strategic partners and/or selling services and products derived from this technology. Currently, we have seven patents patent issued related to our technologies: 1) ultrafine grinding and 2) ultrafine separation.
There can be no assurance we will be able to carry out our development plans for our technology. Our ability to pursue this strategy is subject to the availability of additional capital and further development of our technology. We also need to finance the cost of effectively protecting our intellectual property rights in the United States (“US”) and abroad where we intend to market our technology and products.
-15- |
Critical Accounting Policies and Estimates
The preparation of our consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“US GAAP”) requires management to make estimates, judgments and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amount of expenses during the reporting period. On an ongoing basis, we evaluate our estimates which are based on historical experience and on other assumptions that we believe to be reasonable under the circumstances. The result of these evaluations forms the basis for making judgments about the carrying values of assets and liabilities and the reported amount of expenses that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions. The following accounting policies require significant management judgments and estimates:
We account for our business acquisitions under the purchase method of accounting in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 805, "Business Combinations." The total cost of acquisitions is allocated to the underlying net assets, based on their respective estimated fair values. The excess of the purchase price over the estimated fair value of the tangible net assets acquired is recorded as intangibles. Determining the fair value of assets acquired and liabilities assumed requires management's judgment and often involves the use of significant estimates and assumptions, including assumptions with respect to future cash inflows and outflows, discount rates, asset lives, and market multiples, among other items.
We base our estimates on historical experience and various other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities not readily apparent from other sources. There can be no assurance that actual results will not differ from these estimates.
Results of Operations
For the Three Months Ended December 31, 2022 and 2021
Revenues
Revenues were $120,500 and $0 for the three months ended December 31, 2022 and 2021, respectively. The increase in revenue resulted from the sale of electric vehicles.
Cost of Sales
Cost of sales was $92,388 and $0 for the three months ended December 31, 2022 and 2021, respectively.
Gross Profit
Gross profit was $28,112 and $0 for the three months ended December 31, 2022 and 2021, respectively.
General and Administrative Expenses
General and administrative expenses were $136,912 and $212,687 for the three months ended December 31, 2022 and 2021, respectively which is mainly due to the decrease in stock compensation.
-16- |
Interest Income (Expense) and Other
Interest income (expense) and other was $(101,627) and $(91,416) for the three months ended December 31, 2022 and 2021, respectively.
For the Nine Months Ended December 31, 2022 and 2021
Revenues
Revenues were $120,500 and $0 for the nine months ended December 31, 2022 and 2021, respectively. The increase in revenue resulted from the sale of electric vehicles.
Cost of Sales
Cost of sales was $92,388 and $0 for the nine months ended December 31, 2022 and 2021, respectively.
Gross Profit
Gross profit was $28,122 and $0 for the nine months ended December 31, 2022 and 2021, respectively.
General and Administrative Expenses
General and administrative expenses were $423,586 and $624,023 for the nine months ended December 31, 2022 and 2021, respectively which is mainly due to the decrease in stock compensation.
Interest Income (Expense) and Other
Interest income (expense) and other was $(295,143) and $(264,046) for the nine months ended December 31, 2022 and 2021, respectively.
Liquidity and Capital Resources
Net cash used in operating activities was $(58,132) and $(29,480) in the nine months ended December 31, 2022 and 2021, respectively. The increase in cash used for operations was mainly due to an increase in deposit offset by a reduction in accounts payable for the nine months ended December 31, 2022 and 2021, respectively.
Net cash used in investing activities was $254 and $0 in the nine months ended December 31, 2022 and 2021, respectively.
Net cash provided by financing activities was $34,500 and $0 in the nine months ended December 31, 2022 and 2021, respectively. This was primarily due to the proceeds from the issuance of common stock.
-17- |
The Company suffered recurring losses from operations and has an accumulated deficit of $21,284,233 at December 31, 2022. The Company has incurred losses of $690,619 and $888,069 for the nine months ended December 31, 2022 and 2021, respectively. The Company has not continually generated significant revenues. Unless our operations continue to generate significant revenues and cash flows from operating activities, our continued operations will depend on whether we are able to raise additional funds through various sources, such as equity and debt financing, other collaborative agreements and strategic alliances. Our management is actively engaged in seeking additional capital to fund our operations in the short to medium term. Such additional funds may not become available on acceptable terms and there can be no assurance that any additional funding that we do obtain will be sufficient to meet our needs in the short and long term.
Inflation and Seasonality
Inflation has not been material to us during the past five years. Seasonality has not been material to us.
Recent Accounting Pronouncements
Refer to the notes to the consolidated financial statements in our March 31, 2022 Annual Report on Form 10-K for a complete description of recent accounting standards which we have not yet been required to implement and may be applicable to our operation, as well as those significant accounting standards that have been adopted during the current year.
Off-Balance Sheet Arrangements
As of December 31, 2022, we did not have any off-balance sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation S-K.
-18- |
ITEM 3 – QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.
As a “smaller reporting company” as defined by Rule 229.10(f)(1), we are not required to provide the information required by this Item 3.
ITEM 4 - CONTROLS AND PROCEDURES
Evaluation of Disclosure Controls and Procedures: We conducted an evaluation under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures. The term "disclosure controls and procedures", as defined in Rules 13a-15(e) and 15d-15(e) under the Securities and Exchange Act of 1934, as amended ("Exchange Act"), means controls and other procedures of a company that are designed to ensure that information required to be disclosed by the company in the reports it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC's rules and forms. Disclosure controls and procedures also include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company's management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer concluded as of December 31, 2022, that our disclosure controls and procedures are not effective to a reasonable assurance level of achieving such objectives. However, it should be noted that the design of any system of controls is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions, regardless of how remote.
Management's Report on Internal Control Over Financial Reporting: Our management is responsible for establishing and maintaining adequate internal control over financial reporting (“ICFR”) as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act. Our ICFR is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with US GAAP. The internal controls for the Company are provided by executive management's review and approval of all transactions. Our ICFR also includes those policies and procedures that:
- Pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of our assets;
- Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with US GAAP, and that our receipts and expenditures are being made only in accordance with the authorization of our management; and
- Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial statements.
Because of its inherent limitations, ICFR may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
-19- |
Management assessed the effectiveness of the Company's ICFR as of December 31, 2022. In making this assessment, management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission in Internal Control-Integrated Framework. Management's assessment included an evaluation of the design of our ICFR and testing of the operational effectiveness of these controls.
Based on this assessment, management has concluded that as of December 31, 2022, our ICFR was not effective to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with US GAAP.
This quarterly report does not include an attestation report of the Company's registered public accounting firm regarding ICFR. Management's report was not subject to attestation by the Company's registered public accounting firm pursuant to temporary rules of the SEC that permit the Company to provide only management's report in this annual report.
Changes in Internal Control over Financial Reporting: There were no changes in our ICFR during the quarter ending December 31, 2022 that have materially affected, or are reasonably likely to materially affect, our ICFR.
PART II - OTHER INFORMATION
ITEM 1 – LEGAL PROCEEDINGS
We are not a party to any current or pending legal proceedings that, if decided adversely to us, would have a material adverse effect upon our business, results of operations, or financial condition, and we are not aware of any threatened or contemplated proceeding by any governmental authority against us. To our knowledge, we are not a party to any threatened civil or criminal action or investigation.
ITEM 1A – RISK FACTORS
In addition to the other risk factors and information set forth in this report, you should carefully consider the factors discussed in Part I, “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended March 31, 2022, which could materially affect our business, financial condition or future results. The risks described in our Annual Report on Form 10-K is not the only risks facing the Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition, operating results and/or cash flows.
ITEM 2 - UNREGISTERED SALES OF EQUITY SECURITIES
None
ITEM 3 - DEFAULTS UPON SENIOR SECURITIES
None
ITEM 4 - SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
None
ITEM 5 - OTHER INFORMATION
None
-20- |
ITEM 6 – EXHIBITS
Exhibit | Description | ||||
31.1 | Certification of Chief Executive Officer pursuant to Exchange Act Rule 13a-14 and 15d-14 as adopted pursuant to section 302 of the Sarbanes-Oxley Act of 2002. | ||||
31.2 | Certification of Chief Financial Officer pursuant to Exchange Act Rule 13a-14 and 15d-14 as adopted pursuant to section 302 of the Sarbanes-Oxley Act of 2002. | ||||
32 | Certification of the Company’s Chief Executive Officer and Chief Financial Officer, pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | ||||
101.INS | XBRL Instance | ||||
101.SCH | XBRL Taxonomy Extension Schema | ||||
101.CAL | XBRL Taxonomy Extension Calculation | ||||
101.DEF | XBRL Taxonomy Extension Definition | ||||
101.LAB | XBRL Taxonomy Extension Labels | ||||
101.PRE | XBRL Taxonomy Extension Presentation | ||||
-21- |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
AURASOURCE, INC. | ||
Date: February 13, 2023 | /s/ PHILIP LIU | |
Name: Hongliang Philip Liu | ||
Title: Chief Executive Officer | ||
Date: February 13, 2023 | /s/ ERIC STOPPENHAGEN | |
Name: Eric Stoppenhagen | ||
Title: Chief Financial Officer |
-22- |
EXHIBIT INDEX
Exhibit | Description | ||||
31.1 | Certification of Chief Executive Officer pursuant to Exchange Act Rule 13a-14 and 15d-14 as adopted pursuant to section 302 of the Sarbanes-Oxley Act of 2002. | ||||
31.2 | Certification of Chief Financial Officer pursuant to Exchange Act Rule 13a-14 and 15d-14 as adopted pursuant to section 302 of the Sarbanes-Oxley Act of 2002. | ||||
32 | Certification of the Company’s Chief Executive Officer and Chief Financial Officer, pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | ||||
101.INS | XBRL Instance | ||||
101.SCH | XBRL Taxonomy Extension Schema | ||||
101.CAL | XBRL Taxonomy Extension Calculation | ||||
101.DEF | XBRL Taxonomy Extension Definition | ||||
101.LAB | XBRL Taxonomy Extension Labels | ||||
101.PRE | XBRL Taxonomy Extension Presentation | ||||